"The Neurosciences Institute combines the latest treatments & technologies to bring you comprehensive care for brain, spine and nervous system disorders."

During the past decade, Neurosciences Institute - Neurology Charlotte conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurosciences Institute - Neurology Charlotte" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Cytokinetics" with 2 trials sponsored, "Wake Forest University Health Sciences" with 2 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 1 trials sponsored and "CoolTech LLC" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurosciences Institute - Neurology Charlotte" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator, "Cognitive Research Corporation" with 1 trials as a collaborator, "Dohmen Life Science Services" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Neurosciences Institute - Neurology Charlotte" are "Amyotrophic Lateral Sclerosis" (7 trials), "ALS" (1 trials), "Amyotrophic Lateral Sclerosis (ALS)" (1 trials), "Charcot-Marie-Tooth Disease" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Neurosciences Institute - Neurology Charlotte" in a lesser frequency.

Most popular intervention types in "Neurosciences Institute - Neurology Charlotte" are "Drug" (11 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (3 trials), "Placebo" (3 trials), "(RS)-baclofen, naltrexone hydrochloride and D-sorbitol" (1 trials), "Antihistamine" (1 trials) and "BHV-0223" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurosciences Institute - Neurology Charlotte" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Neurosciences Institute - Neurology Charlotte". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Neurosciences Institute - Neurology Charlotte, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Neurosciences Institute - Neurology Charlotte, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".